iwCLL 2019 | The MURANO study: key findings

John Seymour

John Seymour, MBBS, PhD, Peter MacCallum Cancer Center, Melbourne, Australia discusses the biological subsets, safety analysis and serial measurable residual disease (MRD) within the MURANO study (NCT02005471). This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video